시장보고서

상품코드

2084667

일주기 리듬 수면장애 시장 : 치료법별, 용도별, 유통 채널별, 약제별, 최종사용자별, 지역별

Circadian Rhythm Sleep Disorders Market, By Treatment Type, By Application Type, By Distribution Channel, By Drug, By End User, By Geography

발행일: 2026년 06월 | 리서치사: 구분자

Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

가격

Unprintable PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,500

￦ 6,470,000

PDF & Excel (Multi User License - Up to 7 Users)

PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 7,000

￦ 10,064,000

PDF & Excel (Corporate User License)

PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000

￦ 14,378,000

※ 부가세 별도

한글목차

영문목차

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

일주기 리듬 수면장애 시장은 2026년에 27억 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 42억 3,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 6.8%로 성장할 것으로 전망되고 있습니다.

리포트 범위		리포트 상세
기준연도 :	2025년	2026년 시장 규모 :	27억 달러
과거 데이터 기간 :	2020-2024년	예측 기간 :	2026-2033년
2026-2033년 예측 기간의 CAGR :	6.80%	2033년 시장 규모 예측 :	42억 3,000만 달러

이 시장은 수면 건강에 대한 의식의 향상, 진단 능력 향상, 그리고 효과적인 크로노테라피 치료에 대한 수요 확대를 주요 요인으로 삼아 큰 변화를 겪고 있습니다. 수면 위상 지연 증후군, 수면 위상 조기 증후군, 비24시간 수면-각성 장애 등의 일주기 리듬 수면 장애는 자연스러운 수면-각성 주기를 교란시키며, 치료를 소홀히 할 경우 인지 기능 저하, 기분 장애, 대사 기능 장애와 같은 심각한 합병증을 유발할 가능성이 있습니다. 이 시장에는 광요법, 멜라토닌 수용체 작용제, 행동 요법, 병용 요법 및 지지요법 제품 등 폭넓은 치료 옵션이 포함되어 있습니다.

의료 종사자들은 일주기 리듬의 균형을 회복하고 재발을 예방하기 위해 조기 진단과 표적 치료에 점점 더 주력하고 있습니다. 웨어러블 수면 추적기, 액티그래프, 재택 수면 다원 검사 기술의 발전으로 인해 특히 전문 수면 클리닉을 이용하기 어려운 지역에서 사례 탐지 정확도가 향상되고 있습니다. 또한 병용 요법의 활용이 확대됨에 따라 수면 시간과 질을 최적화할 수 있게 되었으며, 그 결과 치료 성과가 향상되고 재발 위험이 감소하고 있습니다.

시장 역학

생체리듬 수면 장애 시장은 수면과 각성의 불일치를 동반하는 장애나 생활 습관에 기인한 생체리듬 장애의 유병률 증가로 인해 큰 성장세를 보이고 있습니다. 시장의 성장은 주로 수면 부족이나 대사성 합병증의 위험이 높은 교대 근무자, 사춘기 청소년, 고령층을 대상으로 한 맞춤형 치료적 개입에 대한 수요가 증가하고 있는 데 기인합니다. 크로노바이오틱 제제, 광요법 기기 및 행동 요법은 질환 관리에 있으며, 핵심적인 역할을 수행하며, 주간 과도한 졸음, 기분 장애, 인지 기능 장애 등의 증상 완화에 기여하고 있습니다. 조기 진단, 맞춤형 치료 및 일반 대중의 인식 제고에 대한 관심이 높아짐에 따라 신뢰성이 높은 일주기 리듬 수면 장애 솔루션에 대한 수요가 증가하고 있습니다.

수면 의학 분야의 인프라 확충이 시장 성장을 지원하고 있습니다. 이는 주로 웨어러블 수면 모니터링 및 원격의료를 통한 진료의 보급, 그리고 멜라토닌 작용제, 라멜테온, 타시멜테온, 아고메라틴과 같은 처방약의 접근성 확대에 힘입어 성장하고 있습니다. 약물 요법과 행동 요법을 결합한 접근법은 일주기 리듬 조절을 개선하고 재발 위험을 줄여줍니다.

수면 건강을 최적화하고자 하는 수요가 증가함에 따라 시장 확대에도 박차를 가하고 있습니다. 수면 클리닉, 병원, 연구 기관, 웰니스 센터는 수면 장애의 진단과 관리에 있으며, 매우 중요한 역할을 하고 있습니다. 일주기 리듬이 건강에 미치는 영향에 대한 인식이 높아짐에 따라 환자의 복약 순응도 강화, 임상 결과 개선, 그리고 보다 안전하고 정밀하게 표적화된 수면 장애 치료법의 개발로 인해 시장이 혜택을 볼 것으로 예상됩니다.

본 조사의 주요 특징

본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
또한 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트를 제공합니다.
본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 일주기 리듬 수면 장애 시장의 주요 기업 개요을 작성하고 있습니다.
이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
본 '일주기 리듬 수면 장애 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
이해관계자 여러분은 일주기 리듬 수면 장애 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.

Report Coverage	Report Details
Base Year:	2025	Market Size in 2026:	USD 2.7 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.80%	2033 Value Projection:	USD 4.23 Bn

The market is undergoing a major transformation mainly driven by rising awareness of sleep health, improved diagnostic capabilities, and growing demand for effective chronotherapy treatments. Circadian rhythm sleep disorders, including delayed sleep phase disorder, advanced sleep phase disorder, and non-24-hour sleep-wake disorder, disrupt the natural sleep-wake cycle and may lead to severe complications like impaired cognitive performance, mood disorders, and metabolic dysfunction if left untreated. The market includes a wide array of treatment options like light therapy, melatonin receptor agonists, behavioral interventions, combination therapies, and supportive care products.

Healthcare providers are increasingly focusing on early diagnosis and targeted treatment to restore circadian alignment and prevent recurrence. The advancements in wearable sleep trackers, actigraphy, and home-based polysomnography are improving case detection, especially in regions with limited access to specialized sleep clinics. In addition, the growing use of combination therapy helps optimize sleep timing and quality, thereby improving treatment outcomes and lowering relapse risk.

Market Dynamics

The Circadian Rhythm Sleep Disorders Market is witnessing a major momentum owing to the rising prevalence of sleep-wake misalignment disorders and lifestyle-induced circadian disruptions. The market's growth is largely attributed to the growing need for targeted therapeutic interventions, especially in shift workers, adolescents, and elderly populations who face higher risks of sleep deprivation and metabolic complications. Chronobiotic medications, light therapy devices, and behavioral sleep interventions play a central role in disorder management, thereby helping reduce symptoms like excessive daytime sleepiness, mood disturbances, and cognitive impairments. The rising focus on early diagnosis, personalized treatment, and public awareness is strengthening the demand for reliable Circadian Rhythm Sleep Disorders solutions.

The expansion of sleep medicine infrastructure is fueling market growth. This is mainly driven by the increasing adoption of wearable sleep monitoring, telemedicine-based consultations, and wider availability of prescription therapies like melatonin agonists, ramelteon, tasimelteon, and agomelatine. Combination approaches involving pharmacological and behavioral strategies improve circadian alignment and reduce relapse risk.

The rising demand for optimized sleep health is also propelling the market. Sleep clinics, hospitals, research institutions, and wellness centers play a crucial role in identifying and managing sleep disorders. As awareness of circadian health grows, the market is expected to benefit from better patient adherence, improved clinical outcomes, and the development of safer, more targeted sleep disorder therapies.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Circadian Rhythm Sleep Disorders Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Vanda Pharmaceuticals, Aeroflow, Inc., Cephalon, Inc., Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., The Sunbox Company, Verilux, Inc., Northern Light Technologies, Koninklijke Philips N.V., and Amjo Corp.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Circadian Rhythm Sleep Disorders Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Circadian Rhythm Sleep Disorders Market

Market Segmentation

Treatment Type Insights (Revenue, USD Bn, 2026-2033)
Healthy Lifestyle Changes
Bright Light Therapy
Melatonin
Application Type Insights (Revenue, USD Bn, 2026-2033)
Delayed Sleep Phase Disorder
Advanced Sleep Phase Disorder
Jet Lag
Shift Work Disorder
Irregular Sleep Wake Rhythm
Non-24-hour Sleep-wake Syndrome
Distribution Channel Insights (Revenue, USD Bn, 2026-2033)
Institutional Sales
Retail Sales
Drug Insights (Revenue, USD Bn, 2026-2033)
Melatonin
Modafinil
Tasimelteon
End User Insights (Revenue, USD Bn, 2026-2033)
Hospitals
Home Care Settings
Sleep Centers
Regional Insights (Revenue, USD Bn, 2026 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- U.K.
- Germany
- Italy
- France
- Russia
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- North Africa
- Central Africa
- South Africa
Key Players Insights
Vanda Pharmaceuticals
Aeroflow, Inc.
Cephalon, Inc.
Takeda Pharmaceutical Company
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
The Sunbox Company
Verilux, Inc.
Northern Light Technologies
Koninklijke Philips N.V.
Amjo Corp.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By Application Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Drug
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Circadian Rhythm Sleep Disorders Market, By Treatment Type, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Healthy Lifestyle Changes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Bright Light Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Melatonin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

5. Global Circadian Rhythm Sleep Disorders Market, By Application Type, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Delayed Sleep Phase Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Advanced Sleep Phase Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Jet Lag
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Shift Work Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Irregular Sleep Wake Rhythm
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Non-24-hour Sleep-wake Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Global Circadian Rhythm Sleep Disorders Market, By Distribution Channel, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Institutional Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Retail Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

7. Global Circadian Rhythm Sleep Disorders Market, By Drug, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Melatonin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Modafinil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Tasimelteon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

8. Global Circadian Rhythm Sleep Disorders Market, By End User, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Sleep Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

9. Global Circadian Rhythm Sleep Disorders Market, By Region, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Vanda Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Aeroflow, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Cephalon, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Takeda Pharmaceutical Company
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Mylan N.V.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- The Sunbox Company
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Verilux, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Northern Light Technologies
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Koninklijke Philips N.V.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Amjo Corp.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views

11. Section

References
Research Methodology
About Us

일주기 리듬 수면장애 시장 : 치료법별, 용도별, 유통 채널별, 약제별, 최종사용자별, 지역별